monday price action, page-9

The way I see it, in respect of market valuations of PRR; is the removal of a large chunk of the discount applied to such valuations; has been achieved by the approval of Provenge.
Valuations, I would assume would be based on PRR having their drug on the market; and then they would work backwards from there.
Lack of a peer on the market would lead to a significant discount being applied; next would be actual approval; then tentative observations of safety and efficacy; then time to market; cash at hand and so on.
Each one of these obstacles would have a discount applied; the largest of which, at this early stage would be lack of a similar drug on the market and actual approval.
Recent events have eliminated the former and have significantly heightened chances of approval.
Thus I believe PRR's value has been markedly enhanced, not by orders of magnitude, but significantly nonetheless.
As a trader, I had to hold myself back from selling on Friday, because I believe there will be large gains to be made over the next couple of months.
Not holding my breath for a big rise on Monday......be waiting for a trading parcel at 16c...gap filled and upwards from there.
Seeya